Persio Sbarba-Dello

Florence, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension.

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension.

Journal: The Journal of pathology
Published: March 11, 2025

BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake.

BCR::ABL1 expression in chronic myeloid leukemia cells in low oxygen is regulated by glutamine via CD36-mediated fatty acid uptake.

Journal: Cancer cell international
Published: January 02, 2025

Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction.

Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction.

Journal: Oncology research
Published: February 08, 2022

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.

The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.

Journal: International journal of molecular sciences
Published: September 10, 2021

Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential.

Glutamine Availability Controls BCR/Abl Protein Expression and Functional Phenotype of Chronic Myeloid Leukemia Cells Endowed with Stem/Progenitor Cell Potential.

Journal: Cancers
Published: July 15, 2021

Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.

Inhibition of ERK5 Elicits Cellular Senescence in Melanoma via the Cyclin-Dependent Kinase Inhibitor p21.

Journal: Cancer research
Published: April 10, 2021

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.

In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.

Journal: Targeted oncology
Published: August 12, 2020

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells.

Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells.

Journal: Journal of cellular and molecular medicine
Published: March 31, 2020

Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.

Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy.

Journal: International journal of molecular sciences
Published: December 27, 2019

Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.

Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.

Journal: Advances in experimental medicine and biology
Published: July 25, 2019

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors.

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors.

Journal: Journal of biological regulators and homeostatic agents
Published: February 28, 2019

ERK5 inhibition elicits cellular senescence in human melanoma cells.

ERK5 inhibition elicits cellular senescence in human melanoma cells.

Journal: Journal of biological regulators and homeostatic agents
Published: February 28, 2019
Showing 1-12 of 34

Last Updated: 09/26/2026